Clinical trial · Interventional
Abdominal or Transanal TME for Rectal Cancer Therapy
Abdominal or Transanal TME in Therapy of Rectal Cancer: A Retrospective Cohort Study
NCT04969107CI-TRIAL-00068656unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study assessed whether transanal TME in patients with rectal cancer is superior to open, laparoscopic, and robotic TME (abdominal TME (abTME)) regarding oncological outcome, postoperative morbidity and 90-day mortality.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mortality | — | UNRESOLVED | — |
| Postoperative Morbidity | — | UNRESOLVED | — |
| Recurrence | — | UNRESOLVED | — |
| Survival | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| abdTME | Procedure | — | UNRESOLVED |
| taTME | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- transanal TME (taTME)
- description
- patients with rectal cancer receiving transanal TME
- interventionNames
- Procedure: taTME
- type
- ACTIVE_COMPARATOR
- label
- abdominal TME (abTME)
- description
- patients with rectal cancer receiving open, laparoscopic or robotic TME
- interventionNames
- Procedure: abdTME
Primary outcomes (3)
- measure
- Overall survival
- timeFrame
- 60 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * all patients receiving elective total mesorectal excision Exclusion Criteria: * diagnosis other than rectal cancer * partial mesorectal excision * discontinuity resection (no anastomosis) * incomplete Staging * metastatic cancer * lack of follow-up * decline of a retrospective data Analysis * age under 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.